Ascend Capital’s Sanofi SNY Stock Holding History

Ascend Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-289,553	Closed	-$11.1M	–	171
2016 Q3	$11.1M	Buy	289,553 +41,692	+17%	+$1.67M	0.68%	57
2016 Q2	$10.4M	Buy	+247,861	New	+$10.2M	0.68%	53
2014 Q3	–	Sell	-61,027	Closed	-$3.25M	–	210
2014 Q2	$3.25M	Sell	61,027 -182,002	-75%	-$9.66M	0.11%	150
2014 Q1	$12.7M	Buy	+243,029	New	+$12.3M	0.33%	93

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Ascend Capital's SNY Position: Q4 2016 in Review

Ascend Capital sold out of Sanofi (SNY) in Q4 2016, closing a stake of 289,553 shares — an estimated $11.1M sold.

Ascend Capital first reported a position in SNY in Q1 2014 and held it in 4 quarters. The position peaked at $12.7M in Q1 2014. 476 funds tracked by Wall St. Rank hold SNY as of Q4 2016.

Ascend Capital reported no remaining Sanofi position as of Q4 2016 after selling out during the quarter.
Ascend Capital sold 289,553 Sanofi shares in Q4 2016, an estimated $11.1M.
Ascend Capital first reported a position in Sanofi in Q1 2014 and held it in 4 quarters.
Ascend Capital's Sanofi position peaked at $12.7M in Q1 2014.
476 funds tracked by Wall St. Rank held Sanofi as of Q4 2016.

Based on Ascend Capital's 13F filing for Q4 2016, filed 13 Feb 2017.